首页> 外文期刊>Journal of pediatric hematology/oncology: Official journal of the American Society of Pediatric Hematology/Oncology >Delayed renal excretion of methotrexate after a severe anaphylactic reaction to methotrexate in a child with osteosarcoma.
【24h】

Delayed renal excretion of methotrexate after a severe anaphylactic reaction to methotrexate in a child with osteosarcoma.

机译:患有骨肉瘤的儿童对甲氨蝶呤发生严重过敏反应后,甲氨蝶呤的肾脏排泄延迟。

获取原文
获取原文并翻译 | 示例
           

摘要

Although methotrexate is an agent widely used in the practice of pediatric oncology, allergic reactions to methotrexate are most unusual. Most of these reactions typically occur after repeated administration. Here, we report a severe anaphylactoid reaction to the first dose of high-dose methotrexate infusion in a child with osteosarcoma who has also experienced a delayed excretion of methotrexate. Clinicians must be aware of the possibility of a systemic, near-fatal anaphylactic reactions with methotrexate and patients who experience severe anaphylactic reactions should be followed carefully because of the possibility of delayed methotrexate excretion.
机译:尽管甲氨蝶呤是在儿科肿瘤学实践中广泛使用的药物,但对甲氨蝶呤的过敏反应最为罕见。这些反应大多数通常在重复给药后发生。在这里,我们报告了在患有骨肉瘤的儿童中首次服用高剂量甲氨蝶呤后出现严重的类过敏反应,该儿童还经历了甲氨蝶呤的排泄延迟。临床医生必须意识到甲氨蝶呤可能发生全身性,致命性的过敏反应,并且由于甲氨蝶呤排泄延迟的可能性,应认真跟踪经历严重过敏反应的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号